isosorbide-2-mononitrate has been researched along with Coronary Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blasini, R; Brügmann, U; Reiniger, G; Rudolph, W | 1 |
| Kochsiek, K; Schanzenbächer, P | 1 |
| Schuster, P; Trieb, G; Wiechmann, HW | 1 |
| György, K; Papp, JG; Parratt, JR; Rastegar, MA; Végh, A | 1 |
| Bernini, W; De Caterina, R; Giannessi, D; Lazzerini, G; Lombardi, M; Mazzone, A; Moscarelli, E; Weiss, M | 1 |
| Boertz, A; Bonn, R; Cawello, W; Dickmans, HA; Evers, J; Weiss, M | 1 |
| Burkhardt, H; Deuster, U; Loew, D; Rietbrock, N | 1 |
| Rietbrock, N | 1 |
3 trial(s) available for isosorbide-2-mononitrate and Coronary Disease
| Article | Year |
|---|---|
[Prevention of the development of tolerance to isosorbide dinitrate in interval therapy].
Topics: Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Electrocardiography; Heart Rate; Humans; Isosorbide Dinitrate | 1984 |
Inhibition of platelet function during in vivo infusion of isosorbide mononitrates: relationship between plasma drug concentration and hemodynamic effects.
Topics: Coronary Disease; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Infusions, Intravenous; Isosorbide Dinitrate; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxane B2 | 1990 |
[Dose-dependent serum concentration of ISDN and its metabolites following administration of ISDN-retard. Studies under steady-state conditions].
Topics: Aged; Clinical Trials as Topic; Coronary Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Isosorbide Dinitrate; Male; Random Allocation | 1986 |
5 other study(ies) available for isosorbide-2-mononitrate and Coronary Disease
| Article | Year |
|---|---|
[Isosorbide mononitrate or dinitrate in coronary disease?].
Topics: Coronary Disease; Humans; Isosorbide Dinitrate | 1983 |
[Hemodynamic effects of isosorbide-5-mononitrate in coronary heart disease. A comparison of acute and chronic treatment].
Topics: Adult; Aged; Coronary Disease; Drug Evaluation; Electrocardiography; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Pulmonary Wedge Pressure; Time Factors | 1983 |
Isosorbide-2-mononitrate reduces the consequences of myocardial ischaemia, including arrhythmia severity: implications for preconditioning.
Topics: Animals; Coronary Disease; Dogs; Female; Hemodynamics; Isosorbide Dinitrate; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Severity of Illness Index; Ventricular Fibrillation | 2000 |
Pharmacokinetics of isosorbide dinitrate, isosorbide-2-nitrate and isosorbide-5-nitrate in renal insufficiency after repeated oral dosage.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Coronary Disease; Female; Humans; Isosorbide Dinitrate; Kidney Failure, Chronic; Kidney Function Tests; Male; Metabolic Clearance Rate; Middle Aged | 1989 |
[Delayed release forms of nitrates--are they obsolete today?].
Topics: Coronary Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Resistance; Humans; Isosorbide Dinitrate; Nitrates | 1985 |